Articles from Onco-Innovations Limited

Onco-Innovations Announces Non-Brokered LIFE Offering

Not for distribution to United States wire services or for dissemination in the United States

By Onco-Innovations Limited · Via ACCESS Newswire · June 19, 2026

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development

Also Announces Appointment of Mr. Dave Antony as CFO

By Onco-Innovations Limited · Via ACCESS Newswire · June 19, 2026

Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization

VANCOUVER, BC / ACCESS Newswire / June 16, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce, further to its news release dated November 18, 2025, the completion of its pilot project with Kuano Ltd. ("Kuano"), supporting the continued advancement of Onco's PNKP Inhibitor Technology (also known as ONC010) through advanced AI-enabled and quantum-based computational approaches.

By Onco-Innovations Limited · Via ACCESS Newswire · June 16, 2026